Access to drugs for Treatment of Noncommunicable diseases

Source: PLOS Medicine

Summary points:

  • A decade ago, the HIV/AIDS treatment –access crisis helped elevate infectious diseases as a foreign policy issue and mobilized billions in global health aid.
  • A new controversy over patented medicines and their affordability in developing countries is emerging, this time over non communicable diseases (NCDs).
  • Conflicts over patented NCD medications are likely to increase, with potential adverse consequences for patients, drug firms, and developed countries and developing country governments alike.
  • The intergovernmental institutions designated to address trade and global health concerns are unlikely to resolve these conflicts and alternatives to intellectual property have not attached significant donor and multilateral support.
  • Address the NCD treatment –access crisis will require another transformation in global health, this time focusing on low-cost interventions and patient centered, rather than country-focused, strategies.

Access the report here


This entry was posted in Global Fund/GAVI, HIV/Aids, IP Rights, Non Communicable Diseases, Patents, Right to Health, WHO. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s